MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (TSXV: MDX), a data-driven skin health analytics company, today announced the appointment of Monaderm, the Monaco-based skin measurement specialist, as a key European sales agent for SkinSecureā„¢, expanding the commercial reach of its non-invasive, objective biological skin measurement technology, which maps collagen, melanin and hemoglobin non-invasively in living skin in a single 30-second capture, across the European cosmetics and skin research market.

ā€œMonaderm has stood alongside MedX for many years, working with us on the SIAscope technology at the heart of SkinSecureā„¢ and bringing it to researchers and brands who demand precise, non-invasive in vivo chromophore mapping,ā€ said John Gevisser, Chief Executive Officer of MedX Health. ā€œFew teams anywhere understand skin measurement, and the practical realities of efficacy testing, as deeply as they do. As we move into SaaS with SkinSecureā„¢, the data is now live and accessible to Sponsors and CROs at the point of capture. Contract Research Organizations and sponsors can run multi-site trials with an immediacy, and a depth of control over their data and study oversight, that they simply have not had before.ā€

MedX Health Appoints Monaderm as a Representative for SkinSecureā„¢ Across Europe for Beauty and Aesthetics Research

Business Wire